Cargando…

The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up

AIM OF THE STUDY: The purpose of the study was to monitor the effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up. MATERIAL AND METHODS: Fifty six patients with symptomatic uterine fibroids qualified for surgical treatment were included in the prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woźniak, Sławomir, Szkodziak, Piotr, Czuczwar, Piotr, Woźniakowska, Ewa, Paszkowski, Maciej, Milart, Paweł, Paszkowski, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520342/ https://www.ncbi.nlm.nih.gov/pubmed/26327823 http://dx.doi.org/10.5114/pm.2014.41091

Ejemplares similares

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease
por: Czuczwar, Piotr, et al.
Publicado: (2014)

Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study
por: Czuczwar, Piotr, et al.
Publicado: (2018)

Elastography in predicting preterm delivery in asymptomatic, low-risk women: a prospective observational study
por: Wozniak, Slawomir, et al.
Publicado: (2014)

Primary ovarian Burkitt’s lymphoma: a rare oncological problem in gynaecology: a review of literature
por: Stepniak, Anna, et al.
Publicado: (2017)

The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes – a review of literature
por: Czuczwar, Piotr, et al.
Publicado: (2017)

Is it necessary to correct a caesarean scar defect before a subsequent pregnancy? A report of three cases
por: Szkodziak, Piotr, et al.
Publicado: (2019)

Pelvic organ prolapse in women: how is it diagnosed and treated currently?
por: Milart, Paweł, et al.
Publicado: (2015)

Minimally invasive procedures in the management of uterine fibroids
por: Szkodziak, Piotr, et al.
Publicado: (2017)

Ascites Index – an attempt to objectify the assessment of ascites
por: Szkodziak, Piotr, et al.
Publicado: (2018)

Fertility impairment associated with uterine fibroids – a review of literature
por: Lisiecki, Marek, et al.
Publicado: (2017)

The role of the “beret” sign and other markers in ultrasound diagnostic of the acrania–exencephaly–anencephaly sequence stages
por: Szkodziak, Piotr, et al.
Publicado: (2020)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
por: Tsoi, Bernice, et al.
Publicado: (2015)

Safety and efficacy of two repeated cycles of ulipristal acetate in the management of symptomatic uterine fibroid among Indian women
por: Jha, Sangam, et al.
Publicado: (2021)

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism
por: von Wunster, S., et al.
Publicado: (2020)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
por: Geale, Kirk, et al.
Publicado: (2017)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double‐blind, randomized, phase II dose‐finding study
por: Irahara, Minoru, et al.
Publicado: (2019)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?
por: Odejinmi, Funlayo, et al.
Publicado: (2017)

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids
por: Lambrecht, I, et al.
Publicado: (2023)

The safety and tolerance of phytotherapies in menopausal medicine – a review of the literature
por: Czuczwar, Piotr, et al.
Publicado: (2017)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2020)

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids
por: Osuga, Yutaka, et al.
Publicado: (2021)

Green urine sign after laparoscopic chromopertubation as an effect of severe contrast intravasation: a report of three cases
por: Szkodziak, Piotr, et al.
Publicado: (2020)

Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids
por: Morgante, Giuseppe, et al.
Publicado: (2020)

Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
por: Pyra, Krzysztof, et al.
Publicado: (2022)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
por: Rozenberg, Serge, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1qgivt03u801ha3bpon66pt5fp